AU2002305164B2 - Method of inhibiting adhesion formation - Google Patents
Method of inhibiting adhesion formation Download PDFInfo
- Publication number
- AU2002305164B2 AU2002305164B2 AU2002305164A AU2002305164A AU2002305164B2 AU 2002305164 B2 AU2002305164 B2 AU 2002305164B2 AU 2002305164 A AU2002305164 A AU 2002305164A AU 2002305164 A AU2002305164 A AU 2002305164A AU 2002305164 B2 AU2002305164 B2 AU 2002305164B2
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- crg
- het
- orf
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28269301P | 2001-04-10 | 2001-04-10 | |
| US60/282,693 | 2001-04-10 | ||
| PCT/US2002/011285 WO2002083125A1 (en) | 2001-04-10 | 2002-04-10 | Method of inhibiting adhesion formation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002305164A1 AU2002305164A1 (en) | 2003-04-17 |
| AU2002305164B2 true AU2002305164B2 (en) | 2005-07-28 |
Family
ID=23082703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002305164A Ceased AU2002305164B2 (en) | 2001-04-10 | 2002-04-10 | Method of inhibiting adhesion formation |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1385504B1 (enExample) |
| JP (1) | JP4394882B2 (enExample) |
| KR (1) | KR20030087069A (enExample) |
| CN (1) | CN1248692C (enExample) |
| AP (1) | AP2003002894A0 (enExample) |
| AT (1) | ATE417612T1 (enExample) |
| AU (1) | AU2002305164B2 (enExample) |
| BG (1) | BG108217A (enExample) |
| BR (1) | BR0208789A (enExample) |
| CA (1) | CA2443734A1 (enExample) |
| CZ (1) | CZ20032767A3 (enExample) |
| DE (1) | DE60230404D1 (enExample) |
| EA (1) | EA006202B1 (enExample) |
| EC (1) | ECSP034799A (enExample) |
| ES (1) | ES2319877T3 (enExample) |
| HU (1) | HUP0303725A3 (enExample) |
| IL (1) | IL158272A0 (enExample) |
| MA (1) | MA26159A1 (enExample) |
| MX (1) | MXPA03009344A (enExample) |
| NO (1) | NO20034513L (enExample) |
| NZ (1) | NZ528577A (enExample) |
| OA (1) | OA12505A (enExample) |
| PL (1) | PL364526A1 (enExample) |
| UA (1) | UA75395C2 (enExample) |
| WO (1) | WO2002083125A1 (enExample) |
| ZA (1) | ZA200307621B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200635902A (en) * | 2004-12-21 | 2006-10-16 | Smithkline Beecham Corp | Methods and formulations |
| RU2744540C1 (ru) * | 2020-02-18 | 2021-03-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ профилактики спаечного процесса при операциях на брюшной полости в условиях паренхиматозного кровотечения в эксперименте |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998014192A1 (en) * | 1996-10-02 | 1998-04-09 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
-
2002
- 2002-04-10 CN CNB028097874A patent/CN1248692C/zh not_active Expired - Fee Related
- 2002-04-10 HU HU0303725A patent/HUP0303725A3/hu unknown
- 2002-04-10 AP APAP/P/2003/002894A patent/AP2003002894A0/en unknown
- 2002-04-10 KR KR10-2003-7013214A patent/KR20030087069A/ko not_active Abandoned
- 2002-04-10 BR BR0208789-8A patent/BR0208789A/pt not_active IP Right Cessation
- 2002-04-10 IL IL15827202A patent/IL158272A0/xx unknown
- 2002-04-10 JP JP2002580929A patent/JP4394882B2/ja not_active Expired - Fee Related
- 2002-04-10 EA EA200301109A patent/EA006202B1/ru not_active IP Right Cessation
- 2002-04-10 WO PCT/US2002/011285 patent/WO2002083125A1/en not_active Ceased
- 2002-04-10 CA CA002443734A patent/CA2443734A1/en not_active Abandoned
- 2002-04-10 PL PL02364526A patent/PL364526A1/xx not_active Application Discontinuation
- 2002-04-10 ES ES02733968T patent/ES2319877T3/es not_active Expired - Lifetime
- 2002-04-10 NZ NZ528577A patent/NZ528577A/en unknown
- 2002-04-10 MX MXPA03009344A patent/MXPA03009344A/es active IP Right Grant
- 2002-04-10 CZ CZ20032767A patent/CZ20032767A3/cs unknown
- 2002-04-10 DE DE60230404T patent/DE60230404D1/de not_active Expired - Lifetime
- 2002-04-10 AT AT02733968T patent/ATE417612T1/de not_active IP Right Cessation
- 2002-04-10 AU AU2002305164A patent/AU2002305164B2/en not_active Ceased
- 2002-04-10 OA OA1200300271A patent/OA12505A/en unknown
- 2002-04-10 EP EP02733968A patent/EP1385504B1/en not_active Expired - Lifetime
- 2002-10-04 UA UA2003109182A patent/UA75395C2/uk unknown
-
2003
- 2003-09-30 ZA ZA200307621A patent/ZA200307621B/en unknown
- 2003-10-01 BG BG108217A patent/BG108217A/bg unknown
- 2003-10-06 MA MA27339A patent/MA26159A1/fr unknown
- 2003-10-08 NO NO20034513A patent/NO20034513L/no not_active Application Discontinuation
- 2003-10-09 EC EC2003004799A patent/ECSP034799A/es unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998014192A1 (en) * | 1996-10-02 | 1998-04-09 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP034799A (es) | 2004-01-28 |
| JP2004525959A (ja) | 2004-08-26 |
| EP1385504A4 (en) | 2007-03-14 |
| PL364526A1 (en) | 2004-12-13 |
| HUP0303725A3 (en) | 2009-08-28 |
| CZ20032767A3 (cs) | 2004-12-15 |
| OA12505A (en) | 2006-05-29 |
| NO20034513D0 (no) | 2003-10-08 |
| IL158272A0 (en) | 2004-05-12 |
| ZA200307621B (en) | 2004-04-21 |
| CA2443734A1 (en) | 2002-10-24 |
| AP2003002894A0 (en) | 2003-12-31 |
| CN1248692C (zh) | 2006-04-05 |
| ATE417612T1 (de) | 2009-01-15 |
| MXPA03009344A (es) | 2004-02-12 |
| DE60230404D1 (enExample) | 2009-01-29 |
| NO20034513L (no) | 2003-12-04 |
| UA75395C2 (en) | 2006-04-17 |
| NZ528577A (en) | 2005-01-28 |
| ES2319877T3 (es) | 2009-05-14 |
| EA200301109A1 (ru) | 2004-02-26 |
| BG108217A (bg) | 2004-12-30 |
| KR20030087069A (ko) | 2003-11-12 |
| EA006202B1 (ru) | 2005-10-27 |
| WO2002083125A1 (en) | 2002-10-24 |
| EP1385504A1 (en) | 2004-02-04 |
| CN1509170A (zh) | 2004-06-30 |
| MA26159A1 (fr) | 2004-07-01 |
| HUP0303725A2 (hu) | 2004-03-01 |
| BR0208789A (pt) | 2004-03-09 |
| EP1385504B1 (en) | 2008-12-17 |
| JP4394882B2 (ja) | 2010-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024203045B2 (en) | New combination of active agents for the treatment of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD) | |
| CN100377742C (zh) | 包含低分子量凝血酶抑制剂及其药物前体的药用制剂 | |
| WO2008066102A1 (en) | Sustained release preparation | |
| TWI251491B (en) | Pharmaceutical combinations | |
| CN108463224A (zh) | sGC刺激剂用于胃肠功能障碍治疗的应用 | |
| JP2002534477A (ja) | メラガトランの新規使用 | |
| JP2008526953A (ja) | 炎症性疾患のプラジカンテルでの治療 | |
| JP2004533462A (ja) | 血管症の治療のための有機ナイトレートをベースとする化合物 | |
| EP1385504B1 (en) | Method of inhibiting adhesion formation | |
| US20220265776A1 (en) | Combination | |
| AU2002305164A1 (en) | Method of inhibiting adhesion formation | |
| US20070149505A1 (en) | Method of Inhibiting Adhesion Formation | |
| JP2008528704A (ja) | 心臓血管系疾患の治療または予防において使用するためのニトロキシド類 | |
| JP4955392B2 (ja) | 血管内膜過増殖疾患の予防または治療剤 | |
| JP4925406B2 (ja) | 糖尿病性腎症の予防及び／又は治療剤 | |
| CN101219204A (zh) | 包含低分子量凝血酶抑制剂及其药物前体的药用制剂 | |
| JP2003267876A (ja) | 新規な血管狭窄治療剤又は予防剤 | |
| JP2003300902A (ja) | 血管新生阻害剤 | |
| WO2003089426A1 (en) | Medicine for prevention and/or therapy of disseminated intravascular coagulation syndrome | |
| HK1115536A (en) | A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug | |
| MXPA01009080A (en) | Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin | |
| JPWO2001005394A1 (ja) | 臓器移植後の慢性拒絶反応抑制剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |